196 related articles for article (PubMed ID: 25901531)
21. Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
Que NLS; Crowley VM; Duerfeldt AS; Zhao J; Kent CN; Blagg BSJ; Gewirth DT
J Med Chem; 2018 Apr; 61(7):2793-2805. PubMed ID: 29528635
[TBL] [Abstract][Full Text] [Related]
22. Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport.
Ghosh S; Shinogle HE; Galeva NA; Dobrowsky RT; Blagg BS
J Biol Chem; 2016 Apr; 291(16):8309-23. PubMed ID: 26872972
[TBL] [Abstract][Full Text] [Related]
23. Grp94 is Tyr-phosphorylated by Fyn in the lumen of the endoplasmic reticulum and translocates to Golgi in differentiating myoblasts.
Frasson M; Vitadello M; Brunati AM; La Rocca N; Tibaldi E; Pinna LA; Gorza L; Donella-Deana A
Biochim Biophys Acta; 2009 Feb; 1793(2):239-52. PubMed ID: 19000718
[TBL] [Abstract][Full Text] [Related]
24. Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum Hsp90 chaperone GRP94.
Wearsch PA; Voglino L; Nicchitta CV
Biochemistry; 1998 Apr; 37(16):5709-19. PubMed ID: 9548957
[TBL] [Abstract][Full Text] [Related]
25. Structure of unliganded GRP94, the endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational change.
Dollins DE; Immormino RM; Gewirth DT
J Biol Chem; 2005 Aug; 280(34):30438-47. PubMed ID: 15951571
[TBL] [Abstract][Full Text] [Related]
26. Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.
He H; Zatorska D; Kim J; Aguirre J; Llauger L; She Y; Wu N; Immormino RM; Gewirth DT; Chiosis G
J Med Chem; 2006 Jan; 49(1):381-90. PubMed ID: 16392823
[TBL] [Abstract][Full Text] [Related]
27. Discovery and development of purine-scaffold Hsp90 inhibitors.
Chiosis G
Curr Top Med Chem; 2006; 6(11):1183-91. PubMed ID: 16842155
[TBL] [Abstract][Full Text] [Related]
28. Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.
Jung S; Yoon NG; Yang S; Kim D; Lee WS; Hong KB; Lee C; Kang BH; Lee JH; Kang S
Bioorg Med Chem Lett; 2020 Jan; 30(2):126809. PubMed ID: 31839539
[TBL] [Abstract][Full Text] [Related]
29. Interaction of endoplasmic reticulum chaperone GRP94 with peptide substrates is adenine nucleotide-independent.
Wearsch PA; Nicchitta CV
J Biol Chem; 1997 Feb; 272(8):5152-6. PubMed ID: 9030582
[TBL] [Abstract][Full Text] [Related]
30. Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.
Soldano KL; Jivan A; Nicchitta CV; Gewirth DT
J Biol Chem; 2003 Nov; 278(48):48330-8. PubMed ID: 12970348
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of hsp90 paralogs: Structure and binding studies uncover the role of helix 1 in Grp94-selective ligand binding.
Que NLS; Seidler PM; Aw WJ; Chiosis G; Gewirth DT
bioRxiv; 2023 Aug; ():. PubMed ID: 37577523
[TBL] [Abstract][Full Text] [Related]
32. Development of a Grp94 inhibitor.
Duerfeldt AS; Peterson LB; Maynard JC; Ng CL; Eletto D; Ostrovsky O; Shinogle HE; Moore DS; Argon Y; Nicchitta CV; Blagg BS
J Am Chem Soc; 2012 Jun; 134(23):9796-804. PubMed ID: 22642269
[TBL] [Abstract][Full Text] [Related]
33. Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
Jeong JH; Oh YJ; Lho Y; Park SY; Liu KH; Ha E; Seo YH
Eur J Med Chem; 2016 Nov; 124():1069-1080. PubMed ID: 27783977
[TBL] [Abstract][Full Text] [Related]
34. Structural and Functional Analysis of GRP94 in the Closed State Reveals an Essential Role for the Pre-N Domain and a Potential Client-Binding Site.
Huck JD; Que NL; Hong F; Li Z; Gewirth DT
Cell Rep; 2017 Sep; 20(12):2800-2809. PubMed ID: 28930677
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
37. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
[TBL] [Abstract][Full Text] [Related]
38. Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90.
Vilenchik M; Solit D; Basso A; Huezo H; Lucas B; He H; Rosen N; Spampinato C; Modrich P; Chiosis G
Chem Biol; 2004 Jun; 11(6):787-97. PubMed ID: 15217612
[TBL] [Abstract][Full Text] [Related]
39. Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases.
Wang GT; Mantei RA; Hubbard RD; Wilsbacher JL; Zhang Q; Tucker L; Hu X; Kovar P; Johnson EF; Osterling DJ; Bouska J; Wang J; Davidsen SK; Bell RL; Sheppard GS
Bioorg Med Chem Lett; 2010 Oct; 20(20):6067-71. PubMed ID: 20817523
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors.
Shao LD; Su J; Ye B; Liu JX; Zuo ZL; Li Y; Wang YY; Xia C; Zhao QS
J Med Chem; 2017 Nov; 60(21):9053-9066. PubMed ID: 29019670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
